Needham & Company Upgrades Hologic (HOLX) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Leerink Partners Remains Bullish on Hologic (HOLX) as Lower Tax Rate Helps Drive 1Q Results
January 28, 2016 9:31 AM ESTLeerink Partners maintained an Outperform rating on Hologic (NASDAQ: HOLX), and cut the price target to $44.00 (from $47.00), following the company's 1Q earnings report. HOLX reported revenue of $695M, which was $6M ahead of the Street's estimate, with outperformance primarily from GYN and... More
Hologic (HOLX) Tops Q1 EPS by 4c; Guides FY EPS Higher
January 27, 2016 4:07 PM ESTHologic (NASDAQ: HOLX) reported Q1 EPS of $0.46, $0.04 better than the analyst estimate of $0.42. Revenue for the quarter came in at $695.2 million versus the consensus estimate of $688.04 million.
GUIDANCE:
Hologic sees Q2 2016 EPS of $0.45-$0.46, versus the consensus of $0.45. Hologic sees Q2... More
